Brian Burkavage does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Passage BIO, Inc., IO Biotech, Inc., and Damora Therapeutics, Inc..

2023 was Brian Burkavage's most active year for acquiring shares with 3 total transactions. Brian Burkavage's most active month to acquire stocks was the month of February. 2023 saw Brian Burkavage paying a total of $10,125.00 for 60,000 shares, this is the most they've acquired in one year.